Skip to main content
. 2024 Jan-Feb;40(3Part-II):303–307. doi: 10.12669/pjms.40.3.8572

Table-III.

Comparison of adverse reactions between the two groups [n (%)].

Group n Adverse reactions

Pain Nausea and vomiting Abdominal pain Fever Hepatic abscess Hepatic rupture Gastrointestinal hemorrhage Liver dysfunction Total
Control group 64 1 (1.56) 2 (3.13) 1 (1.56) 1 (3.13) 1 (1.56) 2 (3.13) 1 (1.56) 2 (3.13) 11 (17.19)
Observation group 61 0 (0) 1 (1.64) 0 (0) 1 (1.64) 0 (0) 1 (1.64) 0 (0) 1 (1.56) 3 (4.92)
χ2 - - - - - - - - - 4.727
P - - - - - - - - - 0.030